SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000637
Filing Date
2023-01-06
Accepted
2023-01-06 20:00:20
Documents
1
Period of Report
2023-01-04

Document Format Files

Seq Description Document Type Size
1 form4-01062023_080107.html 4  
1 form4-01062023_080107.xml 4 6992
  Complete submission text file 0001415889-23-000637.txt   8320
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
Bazemore Todd (Reporting) CIK: 0001605767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 23516286